No Pharma Money
News & Reports
News November 4, 2019

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

1. Big Pharma’s Zombie Lies Must Die

  • Dr. Peter Bach explains how the U.S. can lower drug prices at little cost to drug discovery. — (Bloomberg)

2. Get into it

  • Rep. Steven Horsford reminds us lowering drug prices is one of the most bipartisan things ever. Get it done, Congress. — (Las Vegas Sun)

3. Patient voices heard

  • Patients who require unaffordable prescriptions to live — Revlimid and insulin — share the red tape and heartbreak. — (Al Jazeera America)

4. Yes, but

  • The cystic fibrosis community (including this CF mom) is rightly celebrating an exciting new drug. But at $311k/year, patients who spent their lifetimes fundraising to create new treatments are sure to be left behind. — (The Washington Post)

5. The Money Train

  • As Big Pharma prepares for what could be one of its most challenging years in Washington, the lobby’s minions swarm Congress to maintain their influence. — (Open Secrets)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.